Destructive intrahepatic bile duct diseases.

Area of Science:

• Hepatology
• Immunology
• Pediatric Gastroenterology

Background:

• Cholestatic liver diseases are characterized by the disappearance of intrahepatic bile ducts, termed "vanishing bile duct" diseases.
• Key conditions in neonates and children include extrahepatic bile duct atresia and intrahepatic bile duct paucity.
• Emerging research points to immunological mechanisms in various forms of bile duct obstruction.

Purpose of the Study:

• To review cholestatic liver diseases characterized by vanishing bile ducts.
• To discuss the roles of immunological mechanisms and recent advancements in understanding these conditions.
• To highlight newly defined entities and iatrogenic causes of bile duct destruction.

Main Methods:

• Literature review of cholestatic liver diseases.
• Analysis of immunological factors contributing to bile duct obstruction.
• Discussion of advancements in imaging and surgical techniques.

Main Results:

• Identified key pediatric entities: extrahepatic bile duct atresia and intrahepatic bile duct paucity.
• Highlighted immunological involvement in primary biliary cirrhosis, graft-versus-host disease, and transplant rejection.
• Acknowledged idiopathic adulthood ductopenia and iatrogenic cholangiopathies as significant conditions.

Conclusions:

• Cholestatic liver diseases encompass a range of conditions with vanishing bile ducts, affecting both pediatric and adult populations.
• Immunology, advanced imaging, and surgical innovations are crucial for understanding and managing these complex liver diseases.
• Further research is needed to clarify the pathogenesis of idiopathic adulthood ductopenia and iatrogenic cholangiopathies.